Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 18, 2024

BUY
$235.51 - $267.98 $822,400 - $935,786
3,492 Added 661.36%
4,020 $1 Million
Q1 2024

May 14, 2024

BUY
$224.58 - $256.19 $118,578 - $135,268
528 New
528 $131,000
Q4 2022

Dec 18, 2023

BUY
$241.42 - $282.29 $271,838 - $317,858
1,126 New
1,126 $298,000
Q4 2022

Feb 02, 2023

BUY
$241.42 - $282.29 $271,838 - $317,858
1,126 New
1,126 $299,000

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $167B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Gladius Capital Management LP Portfolio

Follow Gladius Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gladius Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Gladius Capital Management LP with notifications on news.